Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 1,776–1,800 of 7,816 matching trials · page 72 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Antiplatelet Use in Dementia Subtypes NCT07313137 |
NA other |
COMPLETED | 683 | Gulhane Training and Research Hospital OTHER_GOV |
2025-12-31 |
|
Training App for Inhibitory Control Towards Food NCT07075952 Food-specific inhibitory control training delivered through the Foo... Runs in: Italy · 1 site |
NA other |
RECRUITING | 113 | University of Padova OTHER |
2025-12-30 |
|
Decreasing Agitation in Patients With Dementia Through the Use of Weighted Blankets NCT03643991 Weighted Blanket Runs in: United States · 1 site |
NA other |
COMPLETED | 30 | Mayo Clinic OTHER |
2025-12-29 |
|
Study to Evaluate Music Therapy on Irritability and Impulsivity in Patients With Huntington's Disease (MUSIC-HD) NCT06414967 Music Intervention Runs in: France · 1 site |
NA other |
RECRUITING | 15 | Poitiers University Hospital OTHER |
2025-12-29 |
|
Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney) NCT06534723 Wujia Yizhi granules; Placebo Runs in: China · 1 site |
PHASE3 other |
RECRUITING | 570 | Sichuan Jishengtang Pharmaceutical Co., Ltd. INDUSTRY |
2025-12-29 |
|
A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease NCT07307872 Runs in: Switzerland · 1 site |
NA other |
COMPLETED | 150 | Amoneta Diagnostics SAS INDUSTRY |
2025-12-29 |
|
Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients NCT07303998 Active tDCS paired with active online chair yoga Runs in: United States · 1 site |
NA other |
RECRUITING | 40 | University of Arizona OTHER |
2025-12-26 |
|
The Effects of the PsyPills App on Emotion Regulation and Risk Behaviors in Emerging Adults: A Randomized Clinical Trial NCT07304830 PsyPills; MoodWheel Runs in: Romania · 1 site |
NA other |
NOT_YET_RECRUITING | 204 | Babes-Bolyai University OTHER |
2025-12-26 |
|
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy NCT04539041 antisense oligonucleotide; placebo Runs in: Canada; Germany; United Kingdom; United States · 12 sites |
PHASE1 other |
COMPLETED | 59 | Novartis Pharmaceuticals INDUSTRY |
2025-12-24 |
|
Early Cognitive Intervention in Delirium NCT04740567 Cognitive Training; Goal Management Training Runs in: United States · 2 sites |
NA other |
COMPLETED | 283 | Vanderbilt University Medical Center OTHER |
2025-12-24 |
|
Brain Health Program for Older Adults With Subjective Cognitive Decline NCT05934136 My Healthy Brain 1; My Healthy Brain 2 Runs in: United States · 1 site |
NA other |
COMPLETED | 60 | Massachusetts General Hospital OTHER |
2025-12-24 |
|
PET Imaging Evaluation of [11C]SY08 NCT06098612 C11-SY08 Runs in: United States · 1 site |
EARLY_PHASE1 other |
RECRUITING | 40 | Massachusetts General Hospital OTHER |
2025-12-24 |
|
Providing Evidence-Based Approaches for Caregiver Stress Study NCT06451250 Adult Day Service use for family member with dementia Runs in: United States · 1 site |
NA other |
COMPLETED | 42 | Johns Hopkins Bloomberg School of Public Health OTHER |
2025-12-24 |
|
Using SPOZ Technology to Support and Enhance the Vitality Acupunch (VA) Exercise Program for Older Adults With Dementia NCT06941506 VA-SPOZ exercise program; Control Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 142 | Kaohsiung Medical University OTHER |
2025-12-24 |
|
Integrating SPOZ Technology to Support and Enhance the Vitality Acupunch (VA) Exercise Program for Older Adults With Dementia NCT06942832 VA-SPOZ exercise program; Control Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 142 | Kaohsiung Medical University OTHER |
2025-12-24 |
|
A Clinical Trial of AK152 in Healthy Volunteers and Patients With Alzheimer' s Disease NCT07301502 AK152; Placebo Runs in: China · 1 site |
PHASE1 other |
NOT_YET_RECRUITING | 108 | Akeso INDUSTRY |
2025-12-24 |
|
Is Caffeine an Environmental Modifier in Huntington's Disease? NCT03034122 Runs in: France · 10 sites |
NA other |
COMPLETED | 77 | University Hospital, Lille OTHER |
2025-12-23 |
|
Life Enhancing Activities for Family Caregivers (LEAF 2.0) NCT03610698 LEAF Positive Emotion Intervention; Emotion Reporting Control Condition Runs in: United States · 1 site |
NA other |
COMPLETED | 386 | Northwestern University OTHER |
2025-12-23 |
|
Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes NCT04583800 Runs in: France · 1 site |
NA other |
RECRUITING | 600 | University Hospital, Lille OTHER |
2025-12-23 |
|
Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research NCT06343220 Runs in: United States · 1 site |
NA other |
COMPLETED | 131 | Huntington Study Group NETWORK |
2025-12-23 |
|
Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment NCT06618872 PET/CT with RO958 (experimental) Runs in: Switzerland · 2 sites |
NA other |
RECRUITING | 120 | University Hospital, Geneva OTHER |
2025-12-23 |
|
Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A NCT06932809 18F-JSS20-183A PET; Brain MRI; Amyloid PET; Neurological Assessments Runs in: United States · 2 sites |
EARLY_PHASE1 other |
RECRUITING | 90 | University of Pennsylvania OTHER |
2025-12-23 |
|
Low-intensity Hippocampal Transcranial Ultrasound Stimulation for Managing Cognitive and Sleep Dysfunction in Preclinical Alzheimer's Disease NCT07298876 Low-intensity transcranial ultrasound stimulation; Sham low-intensi... Runs in: Hong Kong · 1 site |
NA other |
ENROLLING_BY_INVITATION | 20 | Chinese University of Hong Kong OTHER |
2025-12-23 |
|
Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease NCT03089827 Runs in: United States · 1 site |
NA other |
ENROLLING_BY_INVITATION | 800 | Wake Forest University Health Sciences OTHER |
2025-12-22 |
|
Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People With AD and TBI NCT03734289 Caregiver Coaching Runs in: United States · 1 site |
NA other |
COMPLETED | 88 | University of Alabama at Birmingham OTHER |
2025-12-22 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial